Topics: Celebrity, Meghan Trainor, Health, Explained, Ozempic
American singer Meghan Trainor has recently opened up about joining the star-studded list of celebrities who are now coming forward to share their experiences using Mounjaro.
Earlier this week, the 31-year-old 'All About That Bass' hit-maker took to Instagram where she revealed she has been using the Type 2 diabetes and weight loss management drug in a bid to lose weight.
She claimed that the decision to inject herself with Mounjaro was inspired by her two children, insisting she wanted to become a healthier version of herself for them.
In a lengthy social media post, the Grammy-winning musician shared a super-glam selfie while giving the drug a special 'shout-out'.
Advert
However, the mum-of-two - who shares sons Riley, four, and Barry, 21 months, with Spy Kids alum Daryl Sabara - began her post with a bittersweet admission.
"Feeling so honoured to be recognised by @billboard Women in Music as a Hitmaker - what a dream!" Meghan penned.
"But it’s a little disheartening that so many of the questions (and comments) were focused on my body instead of my music, my passion, or the decade of hard work that got me here.
"This is what it’s like to be a woman in the music industry."
Speaking about her newfound body positivity, however, Meghan added: "No, I don’t look like I did 10 years ago. I’ve been on a journey to be the healthiest, strongest version of myself for my kids and for me.
"I’ve worked with a dietician, made huge lifestyle changes, started exercising with a trainer, and yes, I used science and support (shoutout to Mounjaro!) to help me after my 2nd pregnancy."
The star continued: "And I’m so glad I did because I feel great. Here’s to celebrating talent, growth, and the power of putting yourself first. Let’s keep shifting the convo to what REALLY matters. With love."
Ozempic is used to treat type 2 diabetes - it is not a legitimate weight-loss management drug and is not FDA approved for this use.
The medication works by enhancing insulin secretion but lowers glucagon secretion to lower a person’s blood sugar levels without risking hypoglycaemia, a dangerous condition which can cause seizures.
Mounjaro contains tirzepatide, which is a little different from Ozempic as it's a medication which has been recently approved for weight loss management as well as diabetes as it helps lower blood sugar levels.
It was formerly only approved to be used to treat type 2 diabetes like Ozempic, but unlike the popular jab, this one is actually now approved to aid weight loss.
A key difference between Mounjaro and Ozempic is that Mounjaro targets both the GLP-1 and GIP receptors, instead of just the GLP-1 receptor, which are two appetite-regulating hormones.
So, it’s basically a dual action drug which also improves blood sugar control and supports weight loss.
Mounjaro advises users to talk to their doctor if they have any side effect that 'bothers you or does not go away'.
While noting that everyone can have a different experience, the official website listed the most common side effects experienced by patients taking Mounjaro which include:
"In studies, most nausea, vomiting and diarrhea events occurred while the dose of Mounjaro was being increased," the website continues. These events decreased over time.
"In studies, GI side effects were more common in people taking Mounjaro than people taking placebo, and people taking Mounjaro were more likely to stop treatment because of these side effects."
